GSK has confirmed that doses of Bexsero (meningococcal B vaccine) will again be available toward the end of this week following the supply of an additional 200,000 doses in Australia.
The additional doses are being made available following an update to the Australian licence extending the shelf life to 36 months which allowed increased supply of the vaccine, GSK said in a statement.
See more details at tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Jun 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Jun 17
